• Eone Diagnomics Genomic Center (EDGC) ( was join us to test the effectiveness of our drug candidates using cancer related mRNA expression in animal and human samples.
  • Korea Basic Science Institute performed anti-cancer tests in animal models and supported proteomic, metabolomic analysis to identify the mode of action.



Current Financing Needs
Various pre-clinical tests are ongoing and is going forward for clinical phase 1, which costs approximately $5 million for 2 years.